Evidence map›Paper›PMID 36819851›Full record

ArticleChemical science2023

An

Xuan Wu, Ming Liu, Jie Niu, Qian Liu, Xin Jiang, Yujing Zheng, Yuna Qian, Ying-Ming Zhang, Jianliang Shen, Yu Liu

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Supramolecular Chiral Binding Affinity-Achieved Efficient Synergistic Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xuan WuSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University Wenzhou Zhejiang 325035 China shenjl@wiucas.ac.cn.
Ming LiuSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University Wenzhou Zhejiang 325035 China shenjl@wiucas.ac.cn.
Jie NiuDepartment of Chemistry, State Key Laboratory of Elemento Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University Tianjin 300071 China yuliu@nankai.edu.cn.
Qian LiuUniversity of the Chinese Academy of Sciences Wenzhou Institute Wenzhou Zhejiang 325035 China.
Xin JiangDepartment of Urology, Xiangya Hospital, Central South University Changsha 410008 China.
Yujing ZhengSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University Wenzhou Zhejiang 325035 China shenjl@wiucas.ac.cn.
Yuna QianSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University Wenzhou Zhejiang 325035 China shenjl@wiucas.ac.cn.
Ying-Ming ZhangDepartment of Chemistry, State Key Laboratory of Elemento Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University Tianjin 300071 China yuliu@nankai.edu.cn.
Jianliang ShenSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University Wenzhou Zhejiang 325035 China shenjl@wiucas.ac.cn.
Yu LiuDepartment of Chemistry, State Key Laboratory of Elemento Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University Tianjin 300071 China yuliu@nankai.edu.cn.ORCID https://orcid.org/0000-0003-0967-0919
Chinese Academy of Sciences · CNNankai University · CNWenzhou Medical University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An

Identifiers

PMID36819851
PMCPMC9930980
OpenAlexW4316814558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.